According to CMS plans announced Tuesday, the proposed CMS National Coverage Determination (NCD) would cover approved monoclonal antibodies targeting amyloid through coverage with evidence development (CED). To date, the only…

Five new on-demand webinars are available at no cost, and offer AMA PRA Category 1 Credits™.  These webinars are focused at providing clinical staff tools to address the growing number…

Aducanumab for Treatment of Alzheimer's Disease:  Controversy & Patient Communications 1.5 CMA PRA Category 1 Credits This panel discussion among geriatric specialists will clarify controversial issues surrounding FDA's recent approval…

Champions for Health Joins First Annual San Diego Gives Champions for Health is so excited to be part of San Diego Gives. This is the first annual day of giving…

The mobile app, awarded a Top 10 in 2017 by MedApps, has been updated to include guidance for caregivers, including the addition of a caregiver burden assessment instrument.  The app…

The latest edition (June 2021) of the Alzheimer's Guidelines for Screening, Evaluation & Management of Alzheimer's Disease & Related Dementias is now available for clinicians.